Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44491, first published .
Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

Christos D Argyropoulos   1 , MSci, MSc, PhD ;   Janina Leckler   2, 3 , PhD ;   Jon Salmanton-García   2, 3 , MSc, PhD ;   Marinos Constantinou   1 , BSc ;   Alexandra Alexandrou   1 , BSc ;   Sophia Themistocleous   1 , MSc ;   Evgenia Noula   1 ;   George Shiamakkides   1 , MSc ;   Andria Nearchou   1 ;   Fiona A Stewart   2, 3 , MSc, PhD ;   Kerstin Albus   2, 3 , MSc, PhD ;   Markela Koniordou   4 , MRes ;   Ioannis Kopsidas   4 , MD, PhD ;   Orly Spivak   5 , MSc ;   Margot Hellemans   6 , MSc ;   Greet Hendrickx   6 , MSc ;   Ruth Joanna Davis   7 , MSc ;   Anna Maria Azzini   7 , MD ;   Paula Valle Simon   8, 9 , MSc ;   Antonio Javier Carcas-Sansuan   8, 9 , MD, PhD ;   Helena Hervius Askling   10, 11 , MD, PhD ;   Sirkka Vene   10, 11 , MSc ;   Jana Baranda Prellezo   12 , MSc ;   Elena Álvarez-Barco   13 , PhD ;   Alan J Macken   13 , MSc ;   Romina Di Marzo   14 , BSc ;   Catarina Luís   14 , MSc, PhD ;   Ole F Olesen   14 , PhD ;   Jesus A Frias Iniesta   8, 9 , MSc, PhD ;   Imre Barta   15 , PhD ;   Krisztina Tóth   15 , MD ;   Murat Akova   16 , MD ;   Marc M J Bonten   17, 18 , MD, PhD ;   Miriam Cohen-Kandli   5 , PhD ;   Rebecca Jane Cox   19 , PhD ;   Lenka Součková   20, 21, 22 , PhD ;   Petr Husa   20, 21, 22 , MUDr, PhD ;   Ligita Jancoriene   23, 24 , MD, PhD ;   Odile Launay   25, 26 , MD ;   Jens Lundgren   27 , MD, DMSc ;   Patrick Mallon   13 , PhD ;   Charis Armeftis   1 , MD ;   Laura Marques   28 , MD ;   Pontus Naucler   10, 11 , MD, PhD ;   Jordi Ochando   12 , PhD ;   Evelina Tacconelli   7 , MD, PhD ;   Pierre van Damme   6 , MD, PhD ;   Theoklis Zaoutis   4 , MD, PhD ;   Sanne Hofstraat   29 , MSc ;   Patricia Bruijning-Verhagen   29 , MD, PhD ;   Markus Zeitlinger   30 , MD ;   Oliver A Cornely   2, 3, 31, 32, 33 , MD, PhD ;   Zoi Dorothea Pana   1 , MD, MSc, PhD

1 School of Medicine, European University Cyprus, Nicosia, Cyprus

2 Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

3 Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and Excellence Center for Medical Mycology, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

4 Collaborative Center for Clinical Epidemiology and Outcomes Research, Athens, Greece

5 Ministry of Health of Israel, Jerusalem, Israel

6 VAXINFECTIO, Centre of Evaluation of Vaccination, Faculty of Medicine and Health Science, Universiteit Antwerpen, Antwerp, Belgium

7 Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy

8 Hospital La Paz Institute for Health Research, Madrid, Spain

9 Servicio Madrileño de Salud, Madrid, Spain

10 Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

11 Department of Medicine, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden

12 Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain

13 Centre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Dublin, Ireland

14 European Vaccine Initiative, Heidelberg, Germany

15 National Koranyi Institute for Pulmonology, Budapest, Hungary

16 Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Haceteppe University, Ankara, Turkey

17 Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands

18 Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands

19 Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway

20 Masaryk University, Brno, Czech Republic

21 University Hospital Brno, Brno, Czech Republic

22 Czech Clinical Research Infrastructure Network, Brno, Czech Republic

23 Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania

24 Vilnius University Hospital Santaros klinikos, Medical Faculty, Vilnius University, Vilnius, Lithuania

25 Institut National de la Santé et de la Recherche Médicale - France Recherche Nord & Sud Sida- HIV Hépatites Maladies Infectieuses Émergentes, Paris, France

26 Assistance Publique Hopitaux de Paris, Université Paris Cité, Paris, France

27 Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

28 Centro Hospitalar Universitário do Porto, Porto, Portugal

29 University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands

30 Medizinische Universität Wien, Vienna, Austria

31 Clinical Trials Centre Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

32 Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

33 German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany

Corresponding Author:

  • Zoi Dorothea Pana, MD, MSc, PhD
  • School of Medicine
  • European University Cyprus
  • 6 Diogenis Str.
  • Egkomi
  • Nicosia, 2404
  • Cyprus
  • Phone: 357 94049474
  • Email: z.pana@euc.ac.cy